NovoCure Ltd

Ownership Transactions Reported by 23 Insiders

Symbol
NVCR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
No. 4 The Forum, Grenville Street, St. Helier, Jersey

Insiders trading volume in the past year

NovoCure Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William F. Doyle Executive Chairman, Director $6.97M Aug 2, 2022
Cordova Ashley Chief Financial Officer $6.96M -$13.9K -0.2% Aug 2, 2024
Groenhuysen Wilhelmus Cm Chief Operating Officer $5.26M -$90.4K -1.69% Jun 28, 2024
Weinberg Uri Chief Innovation Officer $4.83M Feb 27, 2024
Leonard Frank X EVP, Pres., Novocure Oncology $4.53M -$73.9K -1.61% Jun 28, 2024
W. Anthony Vernon Director $4.04M -$23K -0.57% Jun 4, 2024
Ben Arye Barak General Counsel $3.48M Jun 28, 2024
Puri Michal Nath Chief Human Resources Officer $3.14M Jun 28, 2024
Giladi Moshe Chief Science Officer $2.41M Feb 27, 2024
Leupin Nicolas Chief Medical Officer $2.11M Feb 27, 2024
Leung Gabriel Director $1.97M -$23K -1.16% Jun 4, 2024
Pritesh Shah Chief Growth Officer $1.58M -$4.83K -0.31% Nov 7, 2023
Todd Longsworth General Counsel $860K Mar 8, 2022
Burke William Patrick Chief Human Resources Officer $841K Jun 30, 2023
Madden Martin J. Director $572K Jun 5, 2024
Ely Benaim Chief Medical Officer $364K Jan 6, 2023
Stafford Kristin Director $198K Jun 5, 2023
Danziger Asaf Chief Executive Officer, Director $186K Jun 28, 2024
Timothy J. Scannell Director $172K -$23K -11.8% Jun 4, 2024
Allyson J. Ocean Director $102K Jun 5, 2024
Jeryl L. Hilleman Director $102K Jun 5, 2024
Hung David Director $102K Jun 5, 2024
Sherilyn McCoy Director $17.2K Jun 9, 2021

Recent Insider Transactions by Companies or Individuals for NovoCure Ltd

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.